News from us and our partners

Tags

Topics

0 results

News
1 November, 2023
Inari Medical expands Its patient-focused mission with agreement to acquire LimFlow
News
30 October, 2023
AAVantgarde appoints Michael Heffernan as board chair
News
26 October, 2023
Betteromics raises $20 million in Series A financing, led by Sofinnova Partners and Triatomic Capital
News
26 October, 2023
L'école AI raises $3M seed from Sofinnova for machine teaching
News
26 October, 2023
Sofinnova Partners raises $200M Digital Medicine Fund
News
25 October, 2023
EnginZyme produces key mRNA vaccine ingredient using biocatalysis
News
25 October, 2023
Mediar Therapeutics announces clinical candidates for lead fibrosis programs, strategic collaborations and key leadership addition
News
24 October, 2023
Arnault Tzanck Institute in Nice, France, completes inaugural robotics surgeries with Moon Surgical's Maestro commercial system
News
23 October, 2023
Mironid appoints Dr Catherine Kelleher as CMO
News
20 October, 2023
Abivax announces the pricing of its initial public offering on the Nasdaq Global Market
News
18 October, 2023
Mablink Bioscience enters an agreement to be acquired by Lilly
News
12 October, 2023
Bon Vivant raises €15M to scale precision fermentation for dairy
News
9 October, 2023
CorWave opens cardiac assist device facility near Paris
News
6 October, 2023
Asceneuron welcomes Barbara Angehrn Pavik as new CEO as it gears up for next phase of growth
News
27 September, 2023
Chroma Medicine appoints Michael Kelly to board of directors
News
27 September, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics for chronic autoimmune and inflammatory disease

Inari Medical expands Its patient-focused mission with agreement to acquire LimFlow

AAVantgarde appoints Michael Heffernan as board chair

Betteromics raises $20 million in Series A financing, led by Sofinnova Partners and Triatomic Capital

L'école AI raises $3M seed from Sofinnova for machine teaching

Sofinnova Partners raises $200M Digital Medicine Fund

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

Mediar Therapeutics announces clinical candidates for lead fibrosis programs, strategic collaborations and key leadership addition

Arnault Tzanck Institute in Nice, France, completes inaugural robotics surgeries with Moon Surgical's Maestro commercial system

Mironid appoints Dr Catherine Kelleher as CMO

Abivax announces the pricing of its initial public offering on the Nasdaq Global Market

Mablink Bioscience enters an agreement to be acquired by Lilly

Bon Vivant raises €15M to scale precision fermentation for dairy

CorWave opens cardiac assist device facility near Paris

Asceneuron welcomes Barbara Angehrn Pavik as new CEO as it gears up for next phase of growth

Chroma Medicine appoints Michael Kelly to board of directors

Sitryx raises additional $39 million to progress development of disease-modifying therapeutics for chronic autoimmune and inflammatory disease